PERCEPTIVE ADVISORS LLC Insider Trading $LABP Landos Biopharma, Inc.
Get free email notifications about insider trading for PERCEPTIVE ADVISORS LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PERCEPTIVE ADVISORS LLC. PERCEPTIVE ADVISORS LLC is 10% Owner in LA JOLLA PHARMACEUTICAL CO ($LJPC) and 10% Owner in VBI VACCINES INC. ($VBIV) and in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in AMICUS THERAPEUTICS INC ($FOLD) and 10% Owner in SCYNEXIS INC ($SCYX) and in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and 10% Owner in Athenex, Inc. ($ATNX) and 10% Owner in ALBIREO PHARMA, INC. ($ALBO) and Director in Lyra Therapeutics, Inc. ($LYRA) and 10% Owner in VBI Vaccines Inc/BC ($VBIV) and 10% Owner in Aldeyra Therapeutics, Inc. ($ALDX) and 10% Owner in ADMA BIOLOGICS, INC. ($ADMA) and 10% Owner in ZOGENIX, INC. ($ZGNX) and 10% Owner in ACELRX PHARMACEUTICALS INC ($ACRX) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and 10% Owner in LEAP THERAPEUTICS, INC. ($LPTX) and 10% Owner in Versartis, Inc. ($VSAR) and in Kadmon Holdings, Inc. ($KDMN) and 10% Owner in Menlo Therapeutics Inc. ($MNLO) and 10% Owner in Corium International, Inc. ($CORI) and 10% Owner in Quotient Ltd ($QTNT) and 10% Owner in Athira Pharma, Inc. ($ATHA) and Director in Athira Pharma, Inc. ($ATHA) and 10% Owner in Global Blood Therapeutics, Inc. ($GBT) and 10% Owner in Verrica Pharmaceuticals Inc. ($VRCA) and 10% Owner in Crinetics Pharmaceuticals, Inc. ($CRNX) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX) and 10% Owner in Dova Pharmaceuticals, Inc. ($DOVA) and 10% Owner in Motus GI Holdings, Inc. ($MOTS) and 10% Owner in Prometheus Biosciences, Inc. ($RXDX) and 10% Owner in Rain Therapeutics Inc. ($RAIN) and Director in Solid Biosciences Inc. ($SLDB) and Director in MeiraGTx Holdings plc ($MGTX) and Director in Landos Biopharma, Inc. ($LABP) and Director in ARYA Sciences Acquisition Corp II ($ARYB).
PERCEPTIVE ADVISORS LLC in Landos Biopharma, Inc.
Trading Symbol: LABPIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PERCEPTIVE ADVISORS LLC: Director
Holdings: 7,077,017 shares
Latest Transaction: Feb 09 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of PERCEPTIVE ADVISORS LLC in Landos Biopharma, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRX, ADMA, AGRX, ALBO, ALDX, FOLD, ARAV, ATNX, ATHA, CATB, CERE, CORI, CRNX, DOVA, GBT, KDMN, LJPC, LABP, LPTX, LYRA, MGTX, MOTS, RXDX, QTNT, RAIN, SCYX, SLDB, VBIV, VBIV, VRCA, MNLO, ZGNX
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 14.60 | 34,951 | 510,285 | 7,299,751 | 7.3 M to 7.3 M (+0.48 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 13.80 | 64,730 | 893,274 | 7,264,800 | 7.2 M to 7.3 M (+0.90 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 13.10 | 1,771 | 23,200 | 7,200,070 | 7.2 M to 7.2 M (+0.02 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 12.53 | 86,671 | 1,085,988 | 7,198,299 | 7.1 M to 7.2 M (+1.22 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 11.38 | 34,611 | 393,873 | 7,111,628 | 7.1 M to 7.1 M (+0.49 %) |
Feb 09 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 11.14 | 27,453 | 305,826 | 7,077,017 | 7 M to 7.1 M (+0.39 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 1,770,600 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,857,795 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,857,795 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,941,769 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Option Exercise | C | 0.00 | 2,941,769 | 0 | 0 | |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | P | 16.00 | 1,250,000 | 20,000,000 | 7,049,564 | 5.8 M to 7 M (+21.55 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 1,770,600 | 0 | 1,770,600 | 0 to 1.8 M |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,857,795 | 0 | 5,799,564 | 2.9 M to 5.8 M (+97.15 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,857,795 | 0 | 5,799,564 | 2.9 M to 5.8 M (+97.15 %) |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,941,769 | 0 | 2,941,769 | 0 to 2.9 M |
Feb 08 2021 | LABP | Landos Biopharma, ... | PERCEPTIVE ADVISORS LLC | Director | Buy | C | 0.00 | 2,941,769 | 0 | 2,941,769 | 0 to 2.9 M |
Page: 1